Macro-encapsulated Therapeutic Cells for Rapid Insulin Distribution
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current encapsulation barriers for therapeutic cells fail to support long-term survival and rapid hormone distribution in diabetes treatment, are not retrievable, and cannot deliver a therapeutic dose effectively due to limited volume and poor vascular proximity.
Innovation Solution
Development of macro-capsules using cellulose sulfate and glucomannan or sodium alginate with a double-barrier design, allowing for high cell density, retrievability, and rapid hormone distribution by facilitating proximity to host vasculature.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If microcapsules are used for cell encapsulation, then immune protection is provided, but the capsules cannot be completely retrieved and have limited volume for therapeutic dose
Solution Approach 1:
The invention divides the encapsulation system into macroscopic capsules (1mm to 1cm diameter) that can be individually handled and retrieved, rather than using microscopic capsules that disperse and cannot be recovered. This segmentation by size enables both immune protection and retrievability.
2Reliability
If microcapsules are used, then immune protection is achieved, but therapeutic dose delivery is impractical requiring multiple implants
Solution Approach 1:
By scaling up capsule size to macroscopic dimensions (1mm to 1cm), each capsule can contain sufficient therapeutic cells to deliver an effective dose, eliminating the need for multiple implants required by microcapsule systems.
3Ease of operation
If subcutaneous implantation is used, then implantation is simple, but hormone distribution to circulation is slow
Solution Approach 1:
The invention uses the omentum as an intermediary implantation site that provides both ease of access and superior vascularization. The omentum serves as a mediator between the simple surgical approach and the need for rapid hormone entry into circulation through its rich blood supply.
4Volume of stationary object
If larger capsule volume is used to deliver therapeutic dose, then cell capacity increases, but proximity to vasculature decreases
Solution Approach 1:
The omentum acts as an intermediary that provides both the volume capacity for large capsules and the vascular proximity for rapid hormone distribution. By implanting macrocapsules in the highly vascularized omentum, the system achieves both increased cell capacity and maintained vascular access.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The macro-capsules enable long-term survival of therapeutic cells, rapid insulin distribution, and effective delivery of a therapeutic dose, addressing the limitations of existing technologies by enhancing cell survival and vascular integration.
Implementation Method 1
the encapsulating barrier must allow passage of gases, nutrients, and waste
Implementation Method 2
the encapsulating barrier must allow passage of gases, nutrients, and waste
Implementation Method 3
Sodium alginate forms a gel-like matrix in the presence of divalent cations, such as calcium or barium
Data Source
AI summary
Described are macro-capsules and barriers that can be used to prepare therapeutic cell implants, methods of encapsulating therapeutic cells, and methods of using the encapsulated cells in the treatment of disease.